Emergent Biosolutions Inc (EBS)
Investing Cash Flow
-$52.30M
Quarterly · Period ending: · USD
EBS Investing Cash Flow
Latest reported-$52.30Mperiod ending
Latest reported-$52.30Mperiod ending
EBS Quarterly Cash from Investing (-$8.90M → -$52.30M)
Quarterly investing cash flow
High-resolution chart · PNG
EBS investing cash flow history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Investing Cash Flow (USD) |
|---|---|
| -52,300,000 | |
| -2,400,000 | |
| -3,900,000 | |
| -3,400,000 | |
| 17,200,000 | |
| 59,500,000 | |
| 28,600,000 | |
| 112,000,000 | |
| -4,600,000 | |
| -10,800,000 | |
| -11,400,000 | |
| -18,900,000 | |
| 257,700,000 | |
| -15,100,000 | |
| -45,400,000 | |
| -271,600,000 | |
| -32,100,000 | |
| -32,200,000 | |
| -46,700,000 | |
| -55,200,000 | |
| -67,000,000 | |
| -56,100,000 | |
| -36,000,000 | |
| -45,700,000 | |
| -45,100,000 | |
| -24,200,000 | |
| -36,100,000 | |
| -15,300,000 | |
| -24,100,000 | |
| -21,400,000 | |
| -848,549,000 | |
| -26,058,000 | |
| -10,978,000 | |
| -11,615,000 | |
| -207,551,000 | |
| -12,776,000 | |
| -9,301,000 | |
| -20,304,000 | |
| -20,014,000 | |
| -16,997,000 | |
| -21,032,000 | |
| -18,214,000 | |
| -11,831,000 | |
| -13,950,000 | |
| -10,599,000 | |
| -9,082,000 | |
| -17,264,000 | |
| -5,221,000 | |
| -4,810,000 | |
| -182,757,000 | |
| -9,354,000 | |
| -44,417,000 | |
| -6,444,000 | |
| -7,679,000 | |
| -12,902,000 | |
| -10,022,000 | |
| -8,592,000 | |
| -8,598,000 | |
| -18,340,000 | |
| -15,809,000 | |
| -7,073,000 | |
| -12,741,000 | |
| -9,414,000 | |
| -5,411,000 | |
| -3,601,000 | |
| -5,030,000 | |
| -18,911,000 | |
| -5,282,000 | |
| -4,339,000 | |
| -4,755,000 | |
| -4,349,000 | |
| -3,921,000 | |
| -12,112,000 | |
| -10,431,000 | |
| -2,772,000 | |
| -13,854,000 | |
| -10,853,000 | |
| -16,490,000 | |
| -8,897,000 |